3rd Generation Organs (3GO)

Advancing cell therapy and drug discovery … data that reliably translates

3rd Generation Organs (3GO) is transforming preclinical testing with its Ex Vivo Organ Perfusion (EVOP) technology, which maintains living, functional organs outside the body for real-time therapeutic testing. Today, more than 90% of drugs fail in clinical trials because current models cannot accurately predict human response. 3GO fills this critical gap by offering a more physiological, translatable platform that improves decision-making in drug development and accelerates treatments for kidney, pancreatic, and metabolic diseases.